Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Both SGS3 and a viral suppressor of RNA silencing have now been shown to ... mRNA transcripts from convergent transcription of either the natural antisense genes or the geminiviral circular ...

HIV-1, like other viruses, lacks the machinery to produce ... "Our team also showed that targeting this RNA structure with antisense molecules could significantly reduce frameshift efficiency ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...